Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 2 trials in Estonia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 3 Country / region: Estonia Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20032
20053
20062
20083
20094
20105
20113
20124
20131
20142
20161
20173
20182
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Terminated6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi10
Boehringer Ingelheim6
Takeda6
AstraZeneca4
Janssen Research & Development, LLC3
Novo Nordisk A/S3
Hoffmann-La Roche2
Lexicon Pharmaceuticals2
Eli Lilly and Company1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 239
Diabetes Mellitus6
Cardiovascular Diseases3
Dyslipidemias2
Glucose Intolerance2
Glucose Metabolism Disorders2
Hyperglycemia2
Diabetes Mellitus, Lipoatrophic1
Diabetes Mellitus, Type 11
Diabetic Nephropathies1

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.